Quantcast

Latest Thyroid Stories

2014-06-19 04:21:28

DIEPENBEEK, Belgium, June 19, 2014 /PRNewswire/ -- Initiates Preclinical Development of Peptide Therapy Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease. Apitope, through its innovative discovery platform, has selected three peptides...

2014-06-18 08:28:28

SOUTH SAN FRANCISCO, Calif., June 18, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the JMP Securities 2014 Healthcare Conference on Wednesday, June 25, 2014 at 11:30 a.m. ET in New York. The live audio webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the website at least 15 minutes prior to the live...

2014-06-03 08:31:46

SOUTH SAN FRANCISCO, Calif., June 3, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the 2014 William Blair Growth Stock Conference on Tuesday, June 10, 2014 at 12:10 p.m. CT in Chicago. The live audio webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the website at least 15 minutes prior to the live webcast...

2014-06-01 23:01:21

Transparency Market Research published a new report "Endocrine Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/endocrine-testing-market.html. Albany, New York (PRWEB) June 01, 2014 According to a new market report published by Transparency Market Research "Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH,...

2014-05-28 08:31:02

SOUTH SAN FRANCISCO, Calif., May 28, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Jefferies 2014 Global Healthcare Conference on Wednesday, June 4, 2014 at 9 a.m. ET in New York. The live audio webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the website at least 15 minutes prior to the live webcast to...

Scientists Seek Answers To Questions About Thyroid Cancer
2014-05-19 03:54:45

Jessica Nimon, NASA The multi-national efforts that go into research aboard the International Space Station show that working together can yield results with universal benefits. This is especially the case when talking about human health concerns such as cancer. Researchers make use of the microgravity environment aboard the space station to seek answers to questions about the nature of cancer cells. With the Microgravity on Human Thyroid Carcinoma Cells (Cellbox-Thyroid) study, recently...

2014-05-13 16:29:13

OTTAWA, May 13, 2014 /CNW/ - The issue: Health Canada has requested a stop sale and recall of the product "Thyroid Gland" (NPN 80044198). The action has been taken because the product contains the prescription drug ingredient thyroid. Products containing thyroid hormone should be used with caution in diabetics, the elderly and patients with high blood pressure. While the product was authorized as a Natural Health Product by Health Canada, products that contain prescription...

2014-05-13 08:33:05

Nuclear radiation blocking drug for civilian distribution part of 14Mil order MOORESVILLE, N.C., May 13, 2014 /PRNewswire/ -- Nukepills.com announces today that the U.S. Department of Health and Human Services (HHS) was recently shipped 6,383,000 tablets of FDA approved potassium iodide for protection against radiation in the event of a nuclear reactor accident. The balance of the total 14 million tablet solicitation by HHS, on behalf of the Nuclear Regulatory Commission (NRC), is...

2014-05-13 08:31:36

SOUTH SAN FRANCISCO, Calif., May 13, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced the launch of its Afirma Malignancy Classifiers to further establish the Afirma Thyroid FNA Analysis as a comprehensive tool for reducing unnecessary surgeries and healthcare costs among the more than 525,000 U.S. patients each year who undergo fine needle aspiration (FNA) biopsies to rule out cancer in thyroid nodules. The Afirma Malignancy Classifiers comprise genomic tests for...

2014-05-07 08:32:27

SOUTH SAN FRANCISCO, Calif., May 7, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) announced that early data demonstrating the company's ability to develop a molecular classifier differentiating interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF), will be presented at the American Thoracic Society (ATS) 2014 International Conference taking place May 16-21, 2014 in San Diego. "We are excited to share our first proof-of-concept data for the development...


Latest Thyroid Reference Libraries

Thyroid And Parathyroid Glands
2013-03-04 13:34:45

The thyroid gland is an endocrine gland located anterior to the trachea and inferior to the thyroid cartilage. It is butterfly shaped with three lobes that make it the largest endocrine organ in the body. Its primary function is to control the body’s metabolism by regulating how quickly the body uses energy, proteins, and hormones. The two lateral lobes are connected by the middle lobe called the isthmus, which lies directly on top of the trachea. The entire gland is enclosed in a...

More Articles (1 articles) »
Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related